UnitedHealth Group Inc. (UNH) reported fiscal 2025 fourth‑quarter revenue of $113.2 billion, a 12% year‑over‑year increase from $100.8 billion in Q4 2024. The company’s adjusted earnings per share rose to $2.11, beating the consensus estimate of $2.09 by $0.02, or 0.9%. The revenue miss relative to the $113.73 billion estimate—though only 0.4% below consensus—underscores the impact of a tighter Medicare Advantage market and higher-than‑expected cost inflation.
Operating earnings for the quarter were $300 million for UnitedHealthcare, the company’s largest operating segment, and $400 million for the overall group. A $1.6 billion restructuring charge and a $799 million cyber‑attack cost, part of the ongoing Change Healthcare recovery, reduced operating earnings. The medical care ratio climbed to 89.1%, reflecting higher medical costs relative to premium revenue and signaling continued margin pressure.
The Q4 2025 results build on a 12% revenue growth trend that has driven UnitedHealth’s top line for the past two years. UnitedHealthcare’s revenue grew 8% to $71.5 billion, driven by a 5% increase in Medicare Advantage enrollment and a 3% rise in commercial health‑plan sales. Optum Health and Optum Rx each reported double‑digit revenue growth, offset by a 4% decline in Optum Insight revenue due to lower consulting fees. Compared with Q4 2024, the company’s adjusted EPS grew from $1.78 to $2.11, a 18% year‑over‑year gain.
Management guided for 2026 revenue of more than $439 billion, a potential decline of 2% from the 2025 total. Adjusted EPS guidance was set above $17.75, a modest increase from the prior guidance of $17.50. The revenue outlook reflects concerns over the federal CMS proposal to keep Medicare Advantage payment rates flat, which could reduce revenue growth in a key segment. The company also highlighted ongoing investments in AI and data analytics to drive future growth, but cautioned that restructuring costs and cyber‑attack recovery would continue to weigh on earnings.
CEO Stephen Hemsley said the company “confronted challenges directly and finished 2025 as a much stronger company, giving us the momentum to better serve those who count on us and continue to improve our core performance.” UnitedHealthcare CEO Tim Noel added that the CMS Advance Notice “does not reflect the reality of medical utilization and cost trends,” underscoring the company’s concern over the proposed Medicare rates. Investors reacted negatively, citing the cautious revenue guidance and the uncertainty around Medicare payments as the primary drivers of the market’s response.
The earnings miss and forward‑looking guidance signal a shift in UnitedHealth’s growth trajectory. While the company remains profitable and continues to invest in technology, the expected revenue decline and regulatory headwinds suggest a more defensive posture for 2026. The company’s focus on cost discipline, restructuring, and AI integration will be critical to maintaining profitability amid a tightening Medicare environment and rising medical costs.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.